Regulus Therapeutics Inc. 4
4 · Regulus Therapeutics Inc. · Filed Feb 5, 2016
Insider Transaction Report
Form 4
GRINT PAUL C
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-02-04+265,000→ 265,000 totalExercise: $6.35Exp: 2026-02-03→ Common Stock (265,000 underlying)
Footnotes (1)
- [F1]25% of the shares vest on January 1, 2017 and the remainder of the shares vest in equal installments on a monthly basis thereafter, such that the option is fully vested on January 1, 2020.